Cargando…
P479: TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K
Autores principales: | Falqués-Costa, Ton, Pilheden, Mattias, Zhang, Qirui, Ahlgren, Louise, Sturesson, Helena, Rönnstrand, Lars, Hyrenius-Wittsten, Axel, Kazi, Julhash U., Hagström-Andersson, Anna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429254/ http://dx.doi.org/10.1097/01.HS9.0000968824.46763.1f |
Ejemplares similares
-
FLT3(N676K) drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
por: Hyrenius-Wittsten, Axel, et al.
Publicado: (2019) -
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
por: Hyrenius-Wittsten, Axel, et al.
Publicado: (2018) -
Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
por: Pilheden, Mattias, et al.
Publicado: (2022) -
Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012) -
The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)